No ads found for this position

Scientists have begun research into the use of tablets as an alternative to injections

No ads found for this position

Agency. Tablets are now also available in the vaccine against the Corona virus, which has been used as an injection. Scientists have begun research to provide tablets instead of injections for those who are afraid to inject. Scientists at the University of Oxford have begun research into the use of injection-free drugs.

According to the British media Daily Mail, Sarah Gilbert, the lead developer of the Oxford-AstraZeneca vaccine, has started working with her team on injectable vaccines. Scientist are looking for an alternative to injecting nasal spray (nasal spray) or tablets.

It is believed that this will also reduce the hassle of temperature management for storage. Professor Gilbert says tablets or nasal sprays work well on immune cells in the lungs, throat and nose. Professor Gilbert told the House of Commons Science and Technology Committee: ‘There are a lot of flu vaccines that are given through nasal sprays. Discussions are also being held on the issue. Those who are afraid of injections will be able to take the tablet. ‘

However, as safety and efficacy remain to be tested, it may take some time for the tablet to become defective, says Professor Gilbert. According to him, the immune response from nasal sprays and tablets may be different than that from injections, but it will have many benefits. Other alternatives to vaccination in the future will also be explored.

Last month, a trial conducted by a British biotech company found that the Corona virus vaccine given to monkeys was very effective. California-based company ImmunityBio has sought regulatory approval for its testing in the UK.

Clinical trials of the tablet have been underway in the United States since January. Similarly, nasal spray tests have been started on people in the UK. The animal was approved for testing by the UK Medicines and Healthcare Products Regulatory Agency after receiving positive safety data in the study.